Day One Opening Remarks

Patient Story: Maddie’s Transplant  
Presented by Nova Nordisk Foundation
Michael Graziano, small-r Films

Global Antimicrobial Resistance Working Group Report Out
Paul Plummer (V), Chair PACCARB, National Institute of Antimicrobial Resistance Research and Education
Jason Newland (V), Vice Chair PACCARB, Washington University in St. Louis

Follow up on PACCARB Pandemic Preparedness Report: Workforce
Amanda Jezek, Infectious Diseases Society of America

Panel 1: Advocacy, the Voice of the Patient to Drive Change

Challenges When Communicating AMR
Vanessa Carter, World Health Organization AMR Task Force

Driving Innovation for Antifungal Development
Robert Purdie, MyCare

The Realities of Accessing Care and Education as a Refugee
Louange Koffi, Registered Nurse, Amahoro Coalition Fellow

Recognizing the Crucial Role Antibiotics Play in Our Lives: The Importance of Sharing Our Experiences with Infection
Rachel Freeman, IQVIA

Panel 2: Companion Animals and Drug Resistance

Companion Animals: Understanding their Unique Regulatory Position
Scott Weese, University of Guelph

The Emergence of Carbapenemase-Producing Organisms in Pets
Stephen Cole, University of Pennsylvania

Detection & Surveillance of Carbapenem-Resistant Organisms from Companion Animals
Karen Alroy, New York City Department of Health & Mental Hygiene

Public Health Response to a One Health Outbreak
Melissa Cumming, Massachusetts Department of Public Health

Day Two Opening Remarks

Drug Resistance as an Emerging Infectious Disease Threat
Daniel Jernigan, Centers for Disease Control and Prevention

Panel 3: Conflict Zones and Drug Resistance

War and Antimicrobial Resistance: a Surgeon’s View
Ghassan Abu-Sittah, University of Glasgow

Antimicrobial Resistance and Stewardship in Displaced Populations in the Middle East 
Souha Kanj, American University of Beirut Medical Center

Rising Rates and Increased Geographic Spread of Resistant Infections from the War in Ukraine
Joanna Gaines, Centers for Disease Control and Prevention

Understanding the Health and Drug Resistance Consequences of the Conflict in Sudan
Engy Hamed, World Health Organization

Panel 4: Unequal Exposure, Unequal Risk: Environmental Racism & Drug Resistance

Environmental Racism and its Impact on Health Disparities
Roshanak Mehdipanah, University of Michigan

Role of Race, Ethnicity, and Socioeconomic Status in Colonization and Community-Acquired Infection with Increasingly Drug-Resistant Pathogens 
Maya Nadimpalli, Emory University

Exploring the Intersection of Racism, Drug Resistance, and Vaccine Equity
Jacinda Abdul-Mutakabbir, University of California San Diego

Antimicrobial Prescribing Disparities and the Pursuit of Pharmacoequity
Jasmine Marcelin, University of Nebraska Medical Center